Transforming Growth Factor-β Expression in Fibropapillomas Induced by Bovine Papillomavirus Type 1, in Normal Bovine Skin, and in BPV-1-Transformed Cells

References

• Akhurst R., Fee F., Balmain A. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature 1988; 331: 363–365
   PubMed Web of Science ®Google Scholar
• Amtmann E., Sauer G. Activation of non-expressed bovine papillomavirus genomes by tumour promoters. Nature 1982; 296: 675–677
   PubMed Web of Science ®Google Scholar
• Assoian R. K., Fleurdelys B. E., Stevenson H. C, Miller P., Madtes D. K., Raines E. W., Ross R., Sporn M. B. Expression and secretion of type fi transforming growth factor by activated human macrophages. Proc. Natl. Acad. Set. USA 1987; 84: 6020–6024
   PubMed Web of Science ®Google Scholar
• Assoian R. K., Komoriya A., Meyers C. A., Miller D. M., Sporn M. B. Tranforming growth factor-β in human platelets. J. Biol. Chem. 1983; 258: 7155–7160
   PubMed Web of Science ®Google Scholar
• Baker C. C., Howley P. M. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J 1987; 6: 1027–1035
   PubMed Web of Science ®Google Scholar
• Black P. R, Hartley J. W., Rowe W. P., Huebner R. J. Transformation of bovine tissue culture cells by bovine papilloma virus. Nature 1963; 199: 1016–1018
   PubMed Web of Science ®Google Scholar
• Chiefetz S., Weatherbee J. A., Tsang M. L-S., Anderson J. K., Mole J. E., Lucas R., Massague J. The transforming growth factor-β system, a complex pattern of cross reactive ligands and receptors. Cell 1987; 48: 409–415
   PubMed Web of Science ®Google Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Church G. M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA 1984; 81: 1991–1995
   PubMed Web of Science ®Google Scholar
• Cromack D. T., Sporn M. B., Roberts A. B., Merino M. J., Dart L. L., Norton J. A. Transforming growth factor-β levels in rat wound chambers. J. Surg. Res. 1987; 42: 622–628
   PubMed Web of Science ®Google Scholar
• Dvoretzky I., Shober R., Chattopadhyay S. K., Lowy D. R. A quantitative in vitro focus assay for bovine papilloma virus. Virology 1980; 103: 369–375
   PubMed Web of Science ®Google Scholar
• Edwards D. R., Murphy G., Reynolds J. J., Whitman S. E., Docherty A. J. P., Angel P., Heath J. K. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6: 1899–1904
   PubMed Web of Science ®Google Scholar
• Ellingsworth L. R., Brennan J. E., Fok K., Rosen D. M., Bentz H., Piez K. A., Seyedin S. M. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor β. J. Biol. Chem. 1986; 261: 12362–12367
   PubMed Web of Science ®Google Scholar
• Espevik T., Figari I. S., Shalaby M. R., Lackides G. A., Lewis G. D., Shepard H. M., Palladino M. A. Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J. Exp. Med. 1987; 166: 571–576
   PubMed Web of Science ®Google Scholar
• Flanders K. C, Roberts A. B., Ling N., Fleurdelys B. E., Sporn M. B. Antibodies to peptide determinants in transforming growth factor β and their applications. Biochemistry 1988; 27: 739–746
   PubMed Web of Science ®Google Scholar
• Flanders K. C., Thompson N. L., Cissel D. S., Van Obberghen-Schilling E., Baker C, Kass M. E., Ellingsworth L. R., Roberts A. B., Sporn M. B. Transforming growth factor-βl: histochemical localization with antibodies to different epitopes. J. Cell. Biol. 1989; 108: 653–660
   PubMed Web of Science ®Google Scholar
• Gerwin B. I., Lechner J. F., Reddel R. R., Roberts A. B., Robbins K. C., Gabrielson E. W., Harris C. C. Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 1987; 47: 6180–6184
   PubMed Web of Science ®Google Scholar
• Heine U. I, Flanders K, Roberts A. B., Munoz E. F., Sporn M. B. Role of transforming growth factor-β in the development of the mouse embryo. J. Cell. Biol. 1987; 105: 2861–2876
   PubMed Web of Science ®Google Scholar
• Howley P. M. The molecular biology of papillomavirus transformation. Am. J. Pathol. 1983; 113: 414–421
   PubMed Web of Science ®Google Scholar
• Ignotz R. A., Massague J. Transforming growth factor-βstimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol. Chem. 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Jakowlew S. B., Dillard P. J., Kondaiah P., Sporn M. B., Roberts A. B. Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-β messenger ribonucleic acid from chick embryo chondrocytes. Mol. Endocrinol. 1988a; 2: 747–755
   PubMed Web of Science ®Google Scholar
• Jakowlew S. B., Dillard P. J., Sporn M. B., Roberts A. B. Complementary deoxyribonucleic acid cloning of an mRNA encoding transforming growth factor-beta 4 from chick embryo chondrocytes. Mol. Endocrinol. 1988b; 2: 1186–1195
   PubMed Web of Science ®Google Scholar
• Jarrett W. F. H. The natural history of bovine papillomavirus infections. Adv. Viral Onco. 1985; 5: 83–101
   Google Scholar
• Jenson A. B., Rosenthal J. D., Olson C., Pass F., Lancaster W. D., Shah K. Immunologic relatedness of papillomaviruses from different species. J. Natl. Cancer Inst. 1980; 64: 495–500
   PubMedGoogle Scholar
• Kehrl J. H., Roberts A. B., Wakefield L. M., Jakowlew S. B., Sporn M. B., Fauci A. S. Transforming growth factor β is an important immunomodulatory protein for human B-lymphocytes. J. Immunol. 1986a; 137: 3855–3860
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S. B., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 1986b; 163: 1037–1050
   PubMed Web of Science ®Google Scholar
• Knabbe C., Lippman M. E., Wakefield L. M., Flanders K, Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–428
   PubMed Web of Science ®Google Scholar
• Lacey M., Alpert S., Hanahan D. Bovine papillomavirus genome elicits skin tumours in transgenic mice. Nature 1986; 322: 609–612
   PubMed Web of Science ®Google Scholar
• Laiho M., Sakesela O., Andreasen P. A., Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J. Cell. Biol. 1986; 103: 2403–2410
   PubMed Web of Science ®Google Scholar
• Lancaster W. D. Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology 1981; 108: 251–255
   PubMed Web of Science ®Google Scholar
• Law M. F., Lowy D. R., Dvoretzky I., Howley P. M. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl. Acad. Sci. USA 1981; 78: 2727–2731
   PubMed Web of Science ®Google Scholar
• Lehnert S. A., Akhurst R. J. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 1988; 104: 263–273
   PubMed Web of Science ®Google Scholar
• Lowy D. R., Dvoretzky I., Shober R., Law M.-F., Engel L., Howley P. M. vitro tumorigenic transformation by a defined subgenomic fragment of bovine papillomavirus DNA. Nature 1980; 287: 72–74
   PubMedGoogle Scholar
• Lund L. R., Riccio A., Andreasen P. A., Nielsen L. S., Kristensen P., Laiho M., Blasi F., Dano K. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type 1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 1987; 6: 1281–1286
   PubMed Web of Science ®Google Scholar
• Madri J. A., Pratt B. M., Tucker A. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J. Cell. Biol. 1988; 106: 1375–1384
   PubMed Web of Science ®Google Scholar
• Olson C. Animal papillomas: historical perspectives. The Papillomaviruses, N. P. Salzman, P. M. Howley. Plenum Press, New York 1987; 39–66
   Google Scholar
• Reiss M., Sartorelli A. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor. Cancer Res. 1987; 47: 6705–6709
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Flanders K, Kondaiah P., Thompson N. L., Van Obberghen-Schilling E., Wakefield L. M., Rossi P., De Crombrugghe B., Heine U. I., Sporn M. B. Transforming growth factor-β: biochemistry and roles in embryo-genesis, tissue repair and remodeling, and carcinogenesis. Rec. Prog. Horm. Res. 1988; 44: 157–197
   PubMedGoogle Scholar
• Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H., Fauci A. S. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation. in vitro. Proc. Natl. Acad. Sci. USA 1986; 83: 4167–4171
   PubMed Web of Science ®Google Scholar
• Rook A. H, Kehrl J H., Wakefield L. M., Roberts A. B., Sporn M. B., Burlington D. B., Lane H. C., Fauci A. S. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 1986; 136: 3916–3920
   PubMed Web of Science ®Google Scholar
• Rosa F., Roberts A. B., Danielpour D., Dart L. L., Sporn M. B., Dawid I. B. Mesoderm induction in amphibians: the role of TGF-β2-like factors. Science 1988; 239: 783–786
   PubMed Web of Science ®Google Scholar
• Rossi P., Karsenty G., Roberts A. B., Roche N. S., Sporn M. B., De Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 1988; 52: 405–414
   PubMed Web of Science ®Google Scholar
• Sippola-Thiele M., Hanahan D., Howley P. M. Cell heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome. Mol. Cell. Biol. 1989; 9: 925–934
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B., Wakefield L. M., De Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J. Cell. Biol. 1987; 105: 1039–1045
   PubMed Web of Science ®Google Scholar
• Ten Dijke P., Hansen P., Iwata K. K., Pieler C., Foulkes J. G. Identification of another member of the transforming growth factor β gene family. Proc. Nail. Acad. Sci. USA 1988; 85: 4715–4719
   PubMed Web of Science ®Google Scholar
• Thomas M., Boiron M., Tanzer J., Levy J. P., Bernard J. vitro transformation of mice by bovine papillomavirus. Nature 1964; 202: 709–710
   PubMed Web of Science ®Google Scholar
• Van Obberghen-Schilling E., Kondaiah P., Ludwig R. L., Sporn M. B., Baker C. C. Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-/5l. Mol. Endocrinol. 1987; 1: 693–698
   PubMedGoogle Scholar
• Van Obberghen-Schilling E., Roche N. S., Flanders K, Sporn M. B., Roberts A. B. Transforming growth factor βi positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 1988; 263: 7741–7746
   PubMed Web of Science ®Google Scholar
• Varga J., Rosenbloom J., Jimenez S. A. Transforming growth factor-β (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem. J 1987; 247: 597–604
   PubMed Web of Science ®Google Scholar